Molekulare Krebstherapeutika - Strategien für die Entdeckung und Entwicklung von Medikamenten-

Ursprünglicher Text
Molecular Cancer Therapeutics – Strategies for Drug Discovery and Development
The Night Tech
(11047)
Angemeldet als gewerblicher Verkäufer
US $139,99
Ca.EUR 118,48
Artikelzustand:
Akzeptabel
Marker on page (see photos.)
Ganz entspannt. Rückgaben akzeptiert.
Versand:
US $21,20 (ca. EUR 17,94) USPS Ground Advantage®.
Standort: Silver Spring, Maryland, USA
Lieferung:
Lieferung zwischen Sa, 27. Sep und Mi, 1. Okt nach 94104 bei heutigem Zahlungseingang
Wir wenden ein spezielles Verfahren zur Einschätzung des Liefertermins an – in diese Schätzung fließen Faktoren wie die Entfernung des Käufers zum Artikelstandort, der gewählte Versandservice, die bisher versandten Artikel des Verkäufers und weitere ein. Insbesondere während saisonaler Spitzenzeiten können die Lieferzeiten abweichen.
Rücknahme:
30 Tage Rückgabe. Käufer zahlt Rückversand. Wenn Sie ein eBay-Versandetikett verwenden, werden die Kosten dafür von Ihrer Rückerstattung abgezogen.
Zahlungen:
   Diners Club 

Sicher einkaufen

eBay-Käuferschutz
Geld zurück, wenn etwas mit diesem Artikel nicht stimmt. Mehr erfahreneBay-Käuferschutz - wird in neuem Fenster oder Tab geöffnet

  • Gratis Rückversand im Inland
  • Punkte für jeden Kauf und Verkauf
  • Exklusive Plus-Deals
Der Verkäufer ist für dieses Angebot verantwortlich.
eBay-Artikelnr.:127058261921

Artikelmerkmale

Artikelzustand
Akzeptabel
Buch mit deutlichen Gebrauchsspuren. Der Einband kann einige Beschädigungen aufweisen, ist aber in seiner Gesamtheit noch intakt. Die Bindung ist möglicherweise leicht beschädigt, in ihrer Gesamtheit aber noch intakt. In den Randbereichen wurden evtl. Notizen gemacht, der Text kann Unterstreichungen und Markierungen enthalten, es fehlen aber keine Seiten und es ist alles vorhanden, was für die Lesbarkeit oder das Verständnis des Textes notwendig ist. Genauere Einzelheiten sowie eine Beschreibung eventueller Mängel entnehmen Sie bitte dem Angebot des Verkäufers. Alle Zustandsdefinitionen aufrufenwird in neuem Fenster oder Tab geöffnet
Hinweise des Verkäufers
“Marker on page (see photos.)”
Personalized
No
ISBN
9780471432029
Kategorie

Über dieses Produkt

Product Identifiers

Publisher
Wiley & Sons, Incorporated, John
ISBN-10
0471432024
ISBN-13
9780471432029
eBay Product ID (ePID)
5956053

Product Key Features

Number of Pages
368 Pages
Publication Name
Molecular Cancer Therapeutics : Strategies for Drug Discovery and Development
Language
English
Subject
Chemotherapy, Life Sciences / Biochemistry, Oncology, Pharmacology
Publication Year
2004
Type
Textbook
Author
George C. Prendergast
Subject Area
Science, Medical
Format
Hardcover

Dimensions

Item Height
0.9 in
Item Weight
29.3 Oz
Item Length
10.2 in
Item Width
7.3 in

Additional Product Features

Intended Audience
Scholarly & Professional
LCCN
2003-022153
Reviews
"...this little book represents the ever-so-important 'and' that links research and development together in a logical and thoughtful manner...a valuable resource for scientists and clinicians alike..." ( New England Journal of Medicine , January 27, 2005) "...an excellent publication.... I recommended it for libraries...those involved in cancer research...those who teach pharmacy and medical students about drugs used in the treatment of cancer." ( The Annals of Pharmacotherapy , December 2004) "...provides an up-to-date overview of the different phases of drug discovery and preclinical development of experimental cancer principles." ( Drug Discovery & Development , September 2004) "...a most informative book, discussing the important evolution in the field of cancer therapeutics..." ( American Journal of Therapeutics , July/August 2004)
Dewey Edition
22
Illustrated
Yes
Dewey Decimal
616.99/4061
Table Of Content
Preface. Contributors. Chapter 1. Introduction (G. Prendergast). Chapter 2. Molecular Cancer Therapeutics: Will the Promise Be Fulfilled? (B. Teicher). Chapter 3. Cancer Genetics and Drug Target Selection (G. Zhang & W. Kaelin). Chapter 4. RNA Interference in Mammals: Journey to the Center of Human Disease (P. Paddison & G. Hannon). Chapter 5. Applications and Issues for Tissue Arrays in Target and Drug Discovery (E. Jonasch, K. Do, C. Logothetis, & T. McDonnell). Chapter 6. Protein Transduction Strategies for Target and Mechanism Validation (S. Ezhevsky & S. Dowdy). Chapter 7. Drug Screening: Assay Development Issues (S. Carroll, J. Inglese, S. Mao, & D. Olson). Chapter 8. Gene Microarray Technologies for Cancer Drug Discovery and Development (R. te Poele, P. Clarke, & P. Workman). Chapter 9. Transgenic Mouse Models of Cancer (T. Bowen & A. Wynshaw-Boris). Chapter 10. Transgenic versus Xenograft Mouse Models of Cancer: Utility and Issues (M. Liu, W. Bishop, Y. Wang, & P. Kirschmeier). Chapter 11. Pharmacodynamic Assays in Cancer Drug Discovery: From Preclinical Validation to Clinical Trial Monitoring (R. Lobell, N. Kohl, & L. Sepp-Lorenzino). Chapter 12. Pharmacokinetic and Toxicology Issues in Cancer Drug Discovery and Development (P. Benfield & B. Car). Chapter 13. Clinical Development Issues (S. Averbuch, M. Wolf, B. El-Rayes, & P. LoRusso). Chapter 14. Intellectual Property and Commercialization Issues in Drug Discovery (L. Malseed). Index.
Synopsis
This invaluable reference promotes understanding of steps involved in developing drug leads for industrial partnering and development. It provides an overview of the strategies for discovery and validation of drug target molecules, and discusses cell- and molecule-based drug screening strategies, as well as mouse models for cancer., As cancer research increasingly becomes an applied science, academic and biotech researchers interested in general principles must think more about how their efforts translate into the clinical arena. At the same time, researchers on the industrial side stand to gain from a better understanding of the latest strategies for target and lead drug discovery. This way the great promise of new approaches to cancer drug development preventions and treatments that will be less toxic and more effective than current drugs through targeting specific molecular features of aberrant cells can finally be fulfilled. Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development offers an up-to-date overview of the different phases of drug discovery and preclinical development of new experimental cancer principles. In tying together the diverse set of disciplines and methods involved in these pursuits, the text covers: Discovery and validation of drug targets Drug screening Animal models Preclinical testing Pharmacology issues Clinical concerns Intellectual property issues Directed to a broad audience of students and professionals in academia and industry, Molecular Cancer Therapeutics provides a comprehensive summary of state-of-the-art strategies for identifying drug targets and developing lead inhibitors. With its coverage of target validation, drug screening, and pharmacokinetics, it is an invaluable reference for those working in oncology as well as the broad range of disciplines concerned with drug discovery and development., Molecular Cancer Therapeutics covers state-of-the-art strategies to identify and develop cancer drug target molecules and lead inhibitors for clinical testing. It provides a thorough treatment of drug target discovery, validation, and development. The introductory chapters provide an overview of pathways to discovery and development of molecular cancer therapeutics. Subsequent chapters progress from initial stages of drug target discovery to drug discovery, development, and testing in preclinical and clinical models. Topics include drug lead screening, drug-to-lead development, proof-of-concept studies, medicinal chemistry issues, intellectual property concerns, and clinical development. This invaluable reference promotes understanding of steps involved in developing drug leads for industrial partnering and development. It provides an overview of the strategies for discovery and validation of drug target molecules, and discusses cell- and molecule-based drug screening strategies, as well as mouse models for cancer. Coverage also includes how to refine drug leads for suitability in clinical testing, the special issues of clinical testing of molecular-targeted drugs, and intellectual property concerns.
LC Classification Number
RC271.C5M655 2004

Artikelbeschreibung des Verkäufers

Rechtliche Informationen des Verkäufers

Ich versichere, dass alle meine Verkaufsaktivitäten in Übereinstimmung mit allen geltenden Gesetzen und Vorschriften der EU erfolgen.
Info zu diesem Verkäufer

The Night Tech

99,2% positive Bewertungen46.363 Artikel verkauft

Mitglied seit Sep 2011
Antwortet meist innerhalb 48 Stunden
Angemeldet als gewerblicher Verkäufer
Shop besuchenKontakt

Detaillierte Verkäuferbewertungen

Durchschnitt in den letzten 12 Monaten
Genaue Beschreibung
4.9
Angemessene Versandkosten
4.8
Lieferzeit
5.0
Kommunikation
5.0

Verkäuferbewertungen (11.619)

Alle Bewertungen
Positiv
Neutral
Negativ
  • e***a (4667)- Bewertung vom Käufer.
    Letzte 6 Monate
    Bestätigter Kauf
    Packaged with exceptional care and shipped promptly. I literally received the package 24 hours after purchasing! Item was in the exact condition as specified in the listing, and we are already up-and-running with it! I cannot say enough good things about this seller, and they are highly recommended. Needless to say, I am very satisfied, and I would purchase from this seller again in a heartbeat! Thank you so much!!! A+++++! :)
  • e***e (65)- Bewertung vom Käufer.
    Letzte 6 Monate
    Bestätigter Kauf
    The item was exactly as described. I was packed in bubble then an additional bubble wrap cushion. Shipping was reasonable and fast from east to west coast.
  • l***d (3445)- Bewertung vom Käufer.
    Letzte 6 Monate
    Bestätigter Kauf
    They was shipped expeditiously and packed with extreme care. It’s exactly as it was described, and it was a good value. I would like to thank the seller for being so conscientious.